{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1573387449615166336.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"NAID","@value":"10010907622"}}],"dc:title":[{"@language":"en","@value":"Rational basis for the development of new antiepileptic drugs"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1583387449615166336","@type":"Researcher","foaf:name":[{"@language":"en","@value":"MUTANI R."}]}],"publication":{"publicationIdentifier":[{"@type":"NCID","@value":"AA10726642"}],"prism:publicationName":[{"@language":"en","@value":"Epilepsy Res"}],"prism:publicationDate":"1991","prism:volume":"3","prism:startingPage":"23","prism:endingPage":"28"},"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1572824499661745280","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two Different Anticonvulsant Actions of Tiagabine in Developing Rats"}]}],"dataSourceIdentifier":[{"@type":"CIA","@value":"10010907622"}]}